Substance Use Tools & Resources    

The Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) Tool consists of a combined screening component (TAPS-1) followed by a brief assessment (TAPS-2) for those who screen positive. Paper versions of the tools are included.

These are presentation slides which demonstrate the impact of stigma with facts and figures. They were presented by John F. Kelly, Ph.D. at the National Association of Drug Court Professionals Conference in Anaheim, CA in June 2016.

Offers information about what physicians should know about youth opioid addiction.

Provides an overview of prior authorization and tips to reduce the burden of prior authorizations in physician practices. It also discusses the future of prior authorizations, including remaining challenges and practice workflow adjustments, as well as advocacy regarding prior authorization at the State level.

Provides information about opioid dependence, buprenorphine, DATA 2000, and ways to find treatment.

Provides information for pregnant women about how taking methadone or buprenorphine may affect delivery, breastfeeding, and newborn infants.

Offers guidance on the use of MAT with extended-release injectable naltrexone for the treatment of OUD. Covers assessing patients, initiating MAT, monitoring progress, and deciding when to end treatment.

Provides guidance to physicians and pharmacists on buprenorphine regulatory requirements, prescribing, dispensing, and safety recommendations and additional information to improve decision making and promote beneficial outcomes.

Includes a short video that demonstrates how to train people to use the VA Auto-Injector Naloxone Kit.

Includes a short video that demonstrates how to train people to use the VA Intramuscular Naloxone Kit.